VINCENT MENG: Open Payments
NPI 1346925963 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,543 in 204 payments from 21 companies in 2025. Trend: 2023 $101 · 2024 $6,603 · 2025 $9,543
Food & beverage: $6,441Consulting: $3,102
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $1,207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $1,096 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $1,076 |
| UCB, Inc. | 13 | $995 |
| E.R. Squibb & Sons, L.L.C. | 5 | $894 |
| Galderma Laboratories, L.P. | 19 | $615 |
| Arcutis Biotherapeutics, Inc. | 11 | $594 |
| Incyte Corporation | 25 | $593 |
| ABBVIE INC. | 34 | $434 |
| Botanix SB Inc | 5 | $313 |
Products named: TREMFYA, Cabtreo, Bimzelx, Winlevi, Zoryve, OPZELURA, NEMLUVIO, DUPIXENT.
Industry payments across CA — which companies pay providers there.
